Regression of microalbuminuria in type 1 diabetic patients: Results of a sequential intervention with improved metabolic control and ACE inhibitors

Acta Diabetologica

Volumn 42, Issue 2, 2005, Pages 87-94

  Vilarrasa, N ^a   Soler, J ^a   Montanya, E ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Ace inhibition; Diabetic nephropathy; Glycaemic control; Microalbuminuria; Type 1 diabetes

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; PERINDOPRIL; QUINAPRIL;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DISEASE DURATION; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; METABOLIC REGULATION; MICROALBUMINURIA; ONSET AGE; PREDICTION; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; URINARY EXCRETION;

ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; REGRESSION ANALYSIS; SMOKING;

EID: 21144434265     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-005-0184-0     Document Type: Article

References (41)

1. Karamanos B, Porta M, Songini M, Metelko Z, Kerenyi Z, Tamas G, Rottiers R, Stevens LK, Fuller JH and the Eurodiab IDDM Complication Study Group (2000) Different risk factors of microangiopathy in patients with type 1 diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 43:348-355
2. Deckert T, Feldt-Rasmussen B, Borch-Johnsen T, Jensen T, Kofoed-Enevoldsen A, Mathisen ER et al (1991) Natural history of diabetic complications: early detection and progression. Diabetic Med 8:833-37
3. Joint Working Party (1988) Renal failure in diabetics in the deficient provision of care in 1985. Diabet Med 5:79-84
4. Borch-Johnsen K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294:1651-1654
5. Andersen AR, Christiansen JS, Andersen JK (1983) Diabetic nephropathy in type 1 insulin-dependent diabetes: an epidemiological study. Diabetologia 25:496-501
6. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432
7. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93
8. Rudberg S, Dahlquist G (1996) Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care 19:369-371
9. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T (1994) The predictive value of microalbuminmia in IDDM. Diabetes Care 17:120-125
10. Tabei B, Al-Kassab A, Ilag L, Zawachi C, Herman W (2001). Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24:1560-1566
11. Bojestig M, Arngvist H, Karlberg B, Ludvigsson J (1996) Glycemic control and prognosis in type 1 diabetic patients with microalbuminuria. Diabetes Care 19:313-317
12. Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 Diabetes. Lancet 341:1306-1309
13. The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
14. United Kingdom Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
15. The Diabetes Control and Complications Trial Research group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complication trial. Kidney Int 47:1703-1720
16. Ohkubo Y, Kishikawa H, Araki E et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non- insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117
17. Feldt-Rasmussen B, Mathiessen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 6:1300-1304
18. Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:305-308
19. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164-170
20. Bangstad H-J, Osterby R, Dahl-Jorgensen K, Berg KJ, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483-490
21. Microalbuminuria Collaborative Study Group (1995) Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 311:973-977
22. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krowleski A (2003) Regression of microalbuminuria in Type 1 diabetes. N Engl J Med 348:2285-2293
23. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving H-H (2004) Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105
24. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N (2004) Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020-1028
25. American Diabetes Association (2003) Clinical Practice Recommendations 2003. Diabetes Care 26:S1-S156
26. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
27. Warran JH, Gearin G, Laffel L, Krolewski AS (1996) Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7:930-937
28. Krowlewski AS, Warram JH, Christieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78:785-794
29. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S (1987) Declining incidence of persistent proteinuria in Type 1 insulin-dependent diabetic patients in Denmark. Diabetes 36:205-209
30. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg B, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18
31. Deckert T, Lauritzen T, Parving H-H, Christiansen JS, Steno Study Group (1983) Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetics. Diab Nephropathy 2:6-10
32. The Kroc Collaborative Study Group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 311:365-372
33. Beck-Nielsen H, Richelsen B, Mogensen CE et al (1985) Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 8:585-589
34. Christensen CK, Christiansen JS, Schimitz A, Christensen T, Hermansen K, Mogensen CE (1987) Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study. J Diabet Complications 1:91-95
35. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U (1991) Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230:101-108
36. The Diabetes Control and Complications Trial (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381-389
37. Parving H-H (1998) Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 41:745-759
38. Warram J, Scott L, Hanna L, Wantman M, Cohen S, Laffel L, Ryan L, Krolewski A (2000) Progression of microalbuminuria to proteinuria in type 1 diabetes. Nonlinear relationship with hyperglycaemia. Diabetes 49:94-99
39. Zhang L, Krentowski G, Albert A, Lefèbvre PJ (2003) Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. Diabet Med 20:580-585
40. Mogensen CE ( 1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689
41. Chiarelli F, Casani A, Verrotti A, Morgese G, Pinelli L (1998) Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors. Acta Paediatr 425:42-45